Previous close | 106.53 |
Open | 110.65 |
Bid | 108.29 x 100 |
Ask | 108.39 x 100 |
Day's range | 105.69 - 108.48 |
52-week range | 36.90 - 110.74 |
Volume | |
Avg. volume | 1,296,571 |
Market cap | 13.301B |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -3.11 |
Earnings date | 01 Aug 2024 - 05 Aug 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 122.25 |
AUSTIN, Texas, June 03, 2024--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA and genetic testing, today announced that it will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024 at 7:40 a.m. PT (10:40 a.m. ET).
Fred Alger Management, an investment management company, released its “Alger Weatherbie Specialized Growth Fund” first quarter 2024 investor letter. A copy of the letter can be downloaded here. US markets performed strongly in Q1, with the S&P Index up 10.56%. Investor confidence rose with the anticipated soft landing of the market. However, Class A shares […]
On May 30, 2024, Gail Marcus, Director at Natera Inc (NASDAQ:NTRA), executed a sale of 2,000 shares of the company at a price of $110.17 per share.